Companies

JPMorgan Active Value ETF

NYSE ARCA: JAVA
$82.20
▼ $0.44 (−0.53%) today
Markets closed · 2:46am ET

JAVA Coverage

Page 9
2:40pm ET
Investing

The 52-Week Low Club (ABK)(MBI)(BAC)(JAVA)(IDEV)

Indevus Pharmaceuticals (IDEV) Bad news on drug trial. Falls to $1.21 from 52-week high of $8.22. Ambac (ABK) Possible downgrade by Moody’s. Drops to $2.45 from 52-week high of $89.33. MBIA (MBI)…

Douglas A. McIntyre
2:59pm ET
Investing

The 52-Week Low Club (PFE)(RF)(EK)(JAVA)(WB)

Wachovia (WB) Sacking of CEO is still driving away shareholders. Down to $21.04 from 52-week high of $54.54. Sun Microsystems (JAVA) sells off on concerns that the company’s bad forecasts could get…

Douglas A. McIntyre
2:08pm ET
Technology

A Viking Funeral For Sun Microsystems (JAVA)

Sun Microsystems (JAVA) hit a new 52-week low of $12.32. The market has believed for some time that the server company will have a poor year with relatively flat revenue and little…

Douglas A. McIntyre
6:11pm ET
Investing

Sun Microsystems (JAVA): Expelling Jonathan Schwartz

Jonathan Schwartz has become the kind of fast-talk, no delivery CEO whom investors loathe. He was the president of Sun Microsystems (JAVA) and in an appalling lack of judgment the company’s board…

Douglas A. McIntyre
3:09pm ET
Investing

Sun (JAVA) Earnings: Solar Eclipse

Sun (NASDAQ: JAVA) showed Wall St. once again that it is simply not a viable or relevant large tech company. Revenues for the third quarter of fiscal 2008 were $3.266 billion, a…

Douglas A. McIntyre
12:56pm ET
Investing

Will Sun Microsystems Live Up To Plan? (JAVA)

Today after the close of trading we’ll get to see earnings out of Sun Microsystems Inc. (NASDAQ: JAVA). The estimates from First Call are $0.18 EPS on $3.38 billion in revenues.  Next…

Douglas A. McIntyre
10:57am ET
Investing

Sun Microsystems (JAVA): The Short Position Builds

The short position in Sun Microsystems (NASDAQ: JAVA) is moving up, For April 15, it jumped by 6.0 million shares to 33 million. The was the sixth largest move up among all…

Douglas A. McIntyre